4CPS-123 Role of docetaxel in combination with cisplatin and capecitabine in advanced gastric cancer

BACKGROUND: Advanced gastric cancer (AGC) does not have a chemotherapy regimen accepted as standard. Docetaxel has demonstrated benefits associated with cisplatin and 5-fluorouracil in a phase III trial but with modest results and high toxicity, and we need to know how it impacts on more fragile pat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Main Authors: Torròn, A Martinez, Alvarez-Manceñido, F, Garcia, I Zapico, Palomo, A Rodriguez, Calero, M Alaguero, Carmona-Bayonas, A, Medical, E Martínez de Castro, Azkarate, A, Mangas, M, Lozano-Blázquez, A
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535175/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.214
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares